Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Health Care

Health Care

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • News

Teva Highlights Long-Term Data From Chorea Associated-Huntington’s Treatment

By Vandana Singh
October 18, 11:18 AM
Teva Pharmaceutical Industries Ltd (NYSE:TEVA) announced results from the ARC-HD trial, an approximately 3-year open-label study evaluating the safety and tolerability…

TEVA

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Movers
  • News
  • Penny Stocks
  • Trading Ideas

Synlogic Touts Positive Data From Rare Inherited Disorder Trial, Pivotal Study To Start Next Year

By Vandana Singh
October 18, 11:15 AM
Synlogic Inc (NASDAQ:SYBX) announced topline data from the Phase 2 Synpheny-1 study in phenylketonuria (PKU), a rare inherited disorder that causes…

SYBX

Read More
1 minute read
  • Biotech
  • Contracts
  • General
  • Health Care
  • News

Silo Pharma Extends Alzheimer’s Therapeutics Research Pact

By Vandana Singh
October 18, 10:41 AM
Silo Pharma Inc (NASDAQ:SILO) entered into an agreement with Columbia University under which Silo has been granted an extension…

SILO

Read More
1 minute read
  • Biotech
  • Contracts
  • General
  • Health Care
  • Large Cap
  • News

Merck Outlicenses Two Preclinical TB Candidates To Bill & Melinda Gates Research Institute

By Vandana Singh
October 18, 9:49 AM
Merck & Co Inc (NYSE:MRK) and the Bill & Melinda Gates Medical Research Institute (Gates MRI) announced a licensing…

MRK

Read More
1 minute read
  • General
  • Health Care
  • M&A
  • Movers
  • News
  • Penny Stocks
  • Trading Ideas

Statera Biopharma Shares Fall After Taking Stake In Holographic Medical Imaging

By Vandana Singh
October 18, 9:27 AM
Statera Biopharma Inc (NASDAQ:STAB) signed a binding Memorandum of Understanding with Holobeam Technologies Inc. Holobeam offers holographic medical imaging and therapeutic technologies…

IMUN

Read More
1 minute read
  • Biotech
  • Earnings
  • General
  • Guidance
  • Health Care
  • Large Cap
  • Movers
  • News
  • Pre-Market Outlook
  • Trading Ideas

Johnson & Johnson Beats Q3 Estimates Led By Strength From Cancer, Crohn’s Disease Drugs, Tightens Guidance

By Vandana Singh
October 18, 8:18 AM
Johnson & Johnson (NYSE:JNJ) has reported Q3 FY22 adjusted earnings of $2.55 per share, down 1.9% Y/Y and slightly ahead…

JNJ

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • M&A
  • Movers
  • News
  • Pre-Market Outlook
  • Small Cap
  • Trading Ideas

LG Chem Scoops AVEO Oncology At 43% Premium

By Vandana Singh
October 18, 7:36 AM
South Korea-based LG Chem Ltd has agreed to acquire AVEO Oncology Inc (NASDAQ:AVEO) for $15.00 per share in an all-cash transaction with an…

AVEO

Read More
2 minute read
  • General
  • Health Care
  • News

BD And Magnolia Medical Technologies To Co-Sell And Co-Market Magnolia’s Steripath And Steripath Micro Initial Specimen Diversion Device Platforms

By Benzinga Newsdesk
October 18, 6:53 AM
BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, and Magnolia Medical Technologies, Inc., today announced a co-exclusive commercial agreement aimed at helping U.S. hospitals

BDX

Read More
1 minute read
  • General
  • Health Care

Acutus Medical Announces Submission Of Premarket Approval Application For AcQBlate Force Sensing Ablation Catheter & System

By Benzinga Newsdesk
October 18, 6:02 AM
Acutus Medical, Inc. (“Acutus” or the “Company”) (NASDAQ:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced

AFIB

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • Initiation
  • Movers
  • News
  • Penny Stocks
  • Price Target
  • Small Cap
  • Trading Ideas

Analyst Thinks This Company’s Bone Marrow Cancer Treatment Can ‘Transform Paradigm’

By Vandana Singh
October 17, 1:59 PM
SVB Leerink initiated coverage on CTI Biopharma Corp (NASDAQ:CTIC) with an Outperform rating and a $13 price target.  CTIC is a commercial-stage…

CTIC

Posts pagination

Previous 1 … 387 388 389 … 478 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service